View details of this raise on Seedstage
San Diego, CA
Developing a seated self-transfer patient lift to enhance mobility and reduce caregiver strain.
- Innovative Design: UpLyft offers a unique seated self-transfer capability without caregiver lifting.
- Market Presence: The device is FDA-registered and available for purchase under government contracts.
- Revenue Generation: UpLyft has generated significant revenue and established scalable manufacturing.
- Patented Technology: The company holds 16 issued patents for its innovative design.
- Mission-Driven: UpLyft aims to improve the lives of mobility-challenged individuals and reduce caregiver injuries.
UpLyft is a patented seated self-transfer patient lift designed to assist individuals with limited mobility in transferring between their bed and wheelchair without the need for caregiver assistance. This innovative device is particularly beneficial for the estimated 41 million Americans who face challenges in getting out of bed daily. UpLyft’s design allows for independent transfers, enhancing the quality of life for wheelchair users and reducing the physical strain on caregivers. The device is also FDA-registered, making it suitable for use in healthcare facilities where it can be operated by nurses and caregivers without any physical lifting.
The company is expanding its reach in the healthcare market, having generated significant revenue and established a scalable manufacturing process. UpLyft holds 16 issued patents and is available for purchase under government contracts, including those with Veterans Affairs. The company’s mission is to improve the lives of mobility-challenged individuals and reduce the risk of injury to caregivers. With a strong leadership team and strategic partnerships, UpLyft is positioned to address a critical need in the healthcare industry, offering a solution that is both efficient and effective.
Company Info
UpLyft offers a seated self-transfer patient lift that enables independent transfers for wheelchair users and reduces caregiver strain.
UpLyft is a company that has developed a unique seated self-transfer patient lift designed to assist individuals with limited mobility. This patented device allows wheelchair users to independently transfer between their bed and wheelchair without the need for caregiver assistance. In healthcare facilities, UpLyft provides a solution for nurses and caregivers to transfer patients without any physical lifting, reducing the risk of injury. The device is FDA-registered and has been recognized for its innovative design, winning the Core77 Design Award in the Health and Wellness Category in 2023.
UpLyft’s product is available for purchase under government contracts, including those with Veterans Affairs, and is supported by a network of dealers across the United States. The company has established scalable manufacturing capabilities and holds 16 issued patents. UpLyft aims to address the needs of an estimated 41 million Americans who require mobility assistance, while also alleviating the physical burden on caregivers and healthcare professionals.





